Cervical cancer screening in immunosuppressed women: Is pap smear enough?

Swati Agrawal, Prerna Tayal, Reena Yadav, Smita Singh
{"title":"Cervical cancer screening in immunosuppressed women: Is pap smear enough?","authors":"Swati Agrawal, Prerna Tayal, Reena Yadav, Smita Singh","doi":"10.4103/jclgtp.jclgtp_14_23","DOIUrl":null,"url":null,"abstract":"Aim: The present study aims to compare Pap test (liquid-based cytology [LBC]) and colposcopy for the detection of preinvasive lesions of the cervix in iatrogenically immunosuppressed women. Methodology: This study was a cross-sectional, observational study conducted on 75 iatrogenically immunosuppressed women in the age group of 25–50 years. The recruited women were screened by Pap test (LBC) and colposcopy at the same visit, and SWEDE score was calculated. Colposcopy-guided biopsies were taken from abnormal areas if the SWEDE score was >5. Results of histopathology were then correlated with colposcopic findings and cytology report. Results: The percentage of women with abnormal Pap test was 6.7% (5 out of 75 women), and the percentage of women with abnormal colposcopy was 9.3% (7 out of 75 women). The percentage of women with histopathology confirmed preinvasive and invasive lesions of the cervix was calculated to be 6.7% (5 out of 75 women). Pap smear (LBC) and colposcopy were found to have almost perfect agreement by the kappa coefficient (0.819) in the detection of preinvasive lesions of the cervix and cervical cancer for iatrogenically immunosuppressed women. Conclusion: Considering the skill and setup requirements associated with colposcopy and almost perfect agreement with the Pap test, the authors conclude that Pap test should continue to be used as the primary screening modality for screening in immunosuppressed women as well. The frequency of screening may be annual rather than 3 yearly in these women to pick up any low-grade lesions which might have been missed by the Pap test.","PeriodicalId":476164,"journal":{"name":"Journal of Colposcopy and Lower Genital Tract Pathology","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Colposcopy and Lower Genital Tract Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jclgtp.jclgtp_14_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: The present study aims to compare Pap test (liquid-based cytology [LBC]) and colposcopy for the detection of preinvasive lesions of the cervix in iatrogenically immunosuppressed women. Methodology: This study was a cross-sectional, observational study conducted on 75 iatrogenically immunosuppressed women in the age group of 25–50 years. The recruited women were screened by Pap test (LBC) and colposcopy at the same visit, and SWEDE score was calculated. Colposcopy-guided biopsies were taken from abnormal areas if the SWEDE score was >5. Results of histopathology were then correlated with colposcopic findings and cytology report. Results: The percentage of women with abnormal Pap test was 6.7% (5 out of 75 women), and the percentage of women with abnormal colposcopy was 9.3% (7 out of 75 women). The percentage of women with histopathology confirmed preinvasive and invasive lesions of the cervix was calculated to be 6.7% (5 out of 75 women). Pap smear (LBC) and colposcopy were found to have almost perfect agreement by the kappa coefficient (0.819) in the detection of preinvasive lesions of the cervix and cervical cancer for iatrogenically immunosuppressed women. Conclusion: Considering the skill and setup requirements associated with colposcopy and almost perfect agreement with the Pap test, the authors conclude that Pap test should continue to be used as the primary screening modality for screening in immunosuppressed women as well. The frequency of screening may be annual rather than 3 yearly in these women to pick up any low-grade lesions which might have been missed by the Pap test.
免疫抑制妇女的子宫颈癌筛查:巴氏涂片足够吗?
目的:本研究旨在比较巴氏试验(液体细胞学[LBC])和阴道镜检查在医源性免疫抑制女性宫颈浸润前病变的检测效果。方法:本研究是一项横断面观察性研究,对年龄在25-50岁之间的75名医源性免疫抑制妇女进行了研究。招募的女性在同一次就诊时通过巴氏试验(LBC)和阴道镜检查进行筛查,并计算SWEDE评分。如果SWEDE评分>5,则在阴道镜引导下从异常区域进行活检。组织病理学结果与阴道镜检查结果和细胞学报告相关联。结果:宫颈抹片检查异常的女性占6.7%(75例中5例),阴道镜检查异常的女性占9.3%(75例中7例)。经组织病理学证实宫颈浸润前病变和浸润性病变的女性比例为6.7%(75名女性中有5名)。巴氏涂片(LBC)和阴道镜检查在检测医源性免疫抑制妇女宫颈癌侵袭前病变时,kappa系数(0.819)几乎完全一致。结论:考虑到与阴道镜检查相关的技能和设置要求以及与巴氏试验几乎完全一致,作者得出结论,巴氏试验也应继续作为免疫抑制妇女筛查的主要筛查方式。筛查的频率可能是每年一次而不是每三年一次,以发现巴氏试验可能遗漏的低级别病变。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书